X-Zell Inc

x-zell™ is a global start-up specialising in rare cell detection technology. backed by y combinator and various high-profile angel investors from around the globe – among them gmail creator paul buchheit – x-zell™ has developed a world-first platform technology capable of isolating and visualizing rare and abnormal cells such as circulating endothelial cells (cec). x-zell™’s platform technology is based on four core modules covering the entire spectrum from blood processing through to cell analysis and reporting – with every step performed in-house using patented and proprietary technology. by combining the wisdom of 4,000 years of pathologic research with x-zell™’s own, cutting-edge technology, x-zell™ ensures robust results and maximum clinical utility across a broad range of medical applications – from research through to medication management, companions diagnostics, relapse control and diagnostic decision-making. more information on www.x-zell.com and @xzellinc